This PDF is the current document as it appeared on Public Inspection on 10/04/2016 at 08:45 am.
An application has been submitted to the Foreign-Trade Zones Board (the Board) by the Puerto Rico Industrial Development Company, grantee of FTZ 7, requesting subzone status for the facility of Romark Global Pharma, LLC, located in Manatí, Puerto Rico. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of the Board (15 CFR part 400). It was formally docketed on September 29, 2016.
The proposed subzone (30 acres) is located at State Road PR-686 Km 0.5, Coto Norte Ward, Manatí. The proposed subzone would be subject to the existing activation limit of FTZ 7. No authorization for production activity has been requested at this time.
In accordance with the Board's regulations, Camille Evans of the FTZ Staff is designated examiner to review the application and make recommendations to the Executive Secretary.
Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary at the address below. The closing period for their receipt is November 14, 2016. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to November 29, 2016.
A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230-0002, and in the “Reading Room” section of the Board's Web site, which is accessible via www.trade.gov/ftz.
For further information, contact Camille Evans at Camille.Evans@trade.gov or (202) 482-2350.Start Signature
Dated: September 29, 2016.
[FR Doc. 2016-24098 Filed 10-4-16; 8:45 am]
BILLING CODE 3510-DS-P